Extensively drug-resistant tuberculosis: current challenges and threats.
about
Identification of M. tuberculosis Rv3441c and M. smegmatis MSMEG_1556 and essentiality of M. smegmatis MSMEG_1556Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatisCrystal Structures of Mycobacterium tuberculosis KasA Show Mode of Action within Cell Wall Biosynthesis and its Inhibition by ThiolactomycinA Slow, Tight Binding Inhibitor of InhA, the Enoyl-Acyl Carrier Protein Reductase from Mycobacterium tuberculosisThe C-Terminal Domain of the Arabinosyltransferase Mycobacterium tuberculosis EmbC Is a Lectin-Like Carbohydrate Binding ModuleIntegration of published information into a resistance-associated mutation database for Mycobacterium tuberculosisMycobacterium tuberculosis AtsG (Rv0296c), GlmU (Rv1018c) and SahH (Rv3248c) Proteins Function as the Human IL-8-Binding Effectors and Contribute to Pathogen Entry into Human NeutrophilsPhenylalanine-rich peptides potently bind ESAT6, a virulence determinant of Mycobacterium tuberculosis, and concurrently affect the pathogen's growthTuberculosis drug resistance mutation databaseMycobacterium tuberculosis phosphoribosylpyrophosphate synthetase: biochemical features of a crucial enzyme for mycobacterial cell wall biosynthesisCharacteristics and treatment outcomes of patients with MDR and XDR tuberculosis in a TB referral hospital in Beijing: a 13-year experienceBiochemical characterization of uracil phosphoribosyltransferase from Mycobacterium tuberculosisReduced virulence of an extensively drug-resistant outbreak strain of Mycobacterium tuberculosis in a murine modelThe antibiotic potential of prokaryotic IMP dehydrogenase inhibitorsDomain- and nucleotide-specific Rev response element regulation of feline immunodeficiency virus production.Relatively low primary drug resistant tuberculosis in southwestern EthiopiaDifferentiation of Crohn's disease from intestinal tuberculosis in India in 2010.Isoniazid inhibits the heme-based reactivity of Mycobacterium tuberculosis truncated hemoglobin NrplC T460C identified as a dominant mutation in linezolid-resistant Mycobacterium tuberculosis strains.New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeutics.Radiolabelling and positron emission tomography of PT70, a time-dependent inhibitor of InhA, the Mycobacterium tuberculosis enoyl-ACP reductase.Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.Mycobacterium tuberculosis: drug resistance and future perspectives.Molecular dissection of phage endolysin: an interdomain interaction confers host specificity in Lysin A of Mycobacterium phage D29.Arabinogalactan and lipoarabinomannan biosynthesis: structure, biogenesis and their potential as drug targets.Epidemiological models of Mycobacterium tuberculosis complex infections.Bis-spirochromanones as potent inhibitors of Mycobacterium tuberculosis: synthesis and biological evaluation.Elucidation of the protonation states of the catalytic residues in mtKasA: implications for inhibitor design.Mutations in rpoB and katG genes of multidrug resistant mycobacterium tuberculosis undetectable using genotyping diagnostic methods.Lantibiotics as prospective antimycobacterial agents.Design, synthesis and characterization of novel inhibitors against mycobacterial β-ketoacyl CoA reductase FabG4.Macromolecular structure and interaction studies of SigF and Usfx in Mycobacterium tuberculosis.Antimycobacterial neolignans isolated from Aristolochia taliscana.Kinetic and mechanistic characterization of Mycobacterium tuberculosis glutamyl-tRNA synthetase and determination of its oligomeric structure in solution.Consolidated presentation of the joint Scientific Opinion of the GMO and BIOHAZ Panels on the “Use of Antibiotic Resistance Genes as Marker Genes in Genetically Modified Plants” and the Scientific Opinion of the GMO Panel on “Consequences of the O...Mechanochemical Synthesis and Biological Evaluation of Novel Isoniazid Derivatives with Potent Antitubercular Activity.New active leads for tuberculosis booster drugs by structure-based drug discovery.Functionalization of 3-chloroformylcoumarin to coumarin Schiff bases using reusable catalyst: an approach to molecular docking and biological studies.Direct Growth Inhibitory Effect of Platelet Activating Factor C-16 and Its Structural Analogs on Mycobacteria
P2860
Q21134089-A55BEAAE-549B-427C-9124-64FDE793CB11Q21134982-8BE0522A-880B-4C61-884B-5CE169E0B9B3Q27656454-4CBC9F1A-189F-477C-AA6E-5508D600E330Q27660104-1402DE18-AC26-41B5-AF13-A26D42EB26B4Q27667217-9FF4A16B-9780-453D-BE7F-CE1A6FAAB7B8Q28087770-4816DA98-28E5-4FAF-AF93-890936150E84Q28117285-A1882572-C52E-48B4-B33B-A2974213C35CQ28471795-83D53D53-83EA-4E18-819A-90984528977CQ28474770-0E4D52B3-A70F-44DA-AFE0-FAA786C254CEQ28476148-5D761C1E-28BA-433F-93CD-DDD275774B9DQ28478005-B528E99C-3B7D-48BC-93B6-B544FD682519Q28486128-FE033C8D-16A0-45BB-96D3-F7E4E7B84199Q28537876-FF3DFF90-FE15-4B1E-97ED-06873730D73CQ30356398-71B9D41C-64B2-440C-9815-25C232C31E8CQ33987860-322B25C9-2C08-45DF-9AB0-E863978E8B96Q34265158-84555B5F-5132-4D15-A6A3-8F28AB368A80Q34521380-E9E1F1F2-A459-4807-8A89-27D89407EB15Q34924586-7B6F538E-61D7-4A3C-9679-863EF429667BQ35941267-AEE62AAC-E1B6-40BD-80DE-AE77EC0954BEQ36057012-B0465843-7109-4B14-9047-7251B997014DQ36167169-6B533BCD-0D31-475A-97FA-FBECBB8C2FA8Q37274766-8ACC0131-6AFA-4D71-AF23-90A54D9DD696Q37506524-380AF910-A57B-48D2-B418-E89683BB1774Q37727646-D8491E45-D901-49CD-A3C1-38AF6292B2F0Q37970706-3CD5AB27-479F-4E76-ACF1-848727484506Q37990315-0AAB0DE6-DF48-4D7C-8D5D-3C2798C98748Q38608751-5CB7580F-500C-4383-8746-7EF276174F6CQ39648923-B5F489E9-17D7-432E-AF94-1FD18C53D18AQ41495006-9F439F08-01F4-4327-9F41-10A881EED645Q41858889-51F55ACB-A609-4E80-AAEB-C85D214F99FEQ43443908-91C425CC-7D67-475B-8B92-4C49975604FFQ43686723-09D748DF-43E7-482D-A660-3463AD2229CCQ44565103-7FDEEA92-2CB8-443B-B21F-D1B5743E8F14Q44606813-70D78315-01D9-4A15-8FBA-A593373EE5B2Q47146838-A81ECCED-EE59-4613-AA30-7ED0736DF841Q47729001-4DE2FA38-69F3-438D-86D8-815D89DE7DD6Q47813934-11EE05C5-E6DC-4100-A865-A8221EE98665Q55267842-2107C52E-575E-480B-9565-E38772229710Q58750099-C5798862-F980-42D4-8DC5-2DE46E3A33B1
P2860
Extensively drug-resistant tuberculosis: current challenges and threats.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Extensively drug-resistant tuberculosis: current challenges and threats.
@en
Extensively drug-resistant tuberculosis: current challenges and threats.
@nl
type
label
Extensively drug-resistant tuberculosis: current challenges and threats.
@en
Extensively drug-resistant tuberculosis: current challenges and threats.
@nl
prefLabel
Extensively drug-resistant tuberculosis: current challenges and threats.
@en
Extensively drug-resistant tuberculosis: current challenges and threats.
@nl
P2860
P1476
Extensively drug-resistant tuberculosis: current challenges and threats.
@en
P2093
Amita Jain
Rajesh Mondal
P2860
P304
P356
10.1111/J.1574-695X.2008.00400.X
P577
2008-05-08T00:00:00Z